Joel BEATTY

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of ARG1 and/or ARG2
- Patent number 12,226,425
- Issue date Feb 18, 2025
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 12,195,447
- Issue date Jan 14, 2025
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as inhibitors of AXL
- Patent number 12,195,482
- Issue date Jan 14, 2025
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 12,103,907
- Issue date Oct 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HIF-2α and methods of use thereof
- Patent number 12,071,411
- Issue date Aug 27, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD73 inhibitors
- Patent number 11,931,343
- Issue date Mar 19, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 11,787,762
- Issue date Oct 17, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
- Patent number 11,407,712
- Issue date Aug 9, 2022
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 11,072,597
- Issue date Jul 27, 2021
- Joel Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 10,399,962
- Issue date Sep 3, 2019
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AS INHIBITORS OF AXL
- Publication number 20240425526
- Publication date Dec 26, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20240254079
- Publication date Aug 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS INHIBITORS OF AXL
- Publication number 20230416277
- Publication date Dec 28, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF
- Publication number 20230159466
- Publication date May 25, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS
- Publication number 20230024302
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HIF-2ALPHA
- Publication number 20230024438
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20230021476
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20220144808
- Publication date May 12, 2022
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ARG1 AND/OR ARG2
- Publication number 20220016143
- Publication date Jan 20, 2022
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD73 INHIBITORS
- Publication number 20210346353
- Publication date Nov 11, 2021
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20210317079
- Publication date Oct 14, 2021
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20210101880
- Publication date Apr 8, 2021
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20180215730
- Publication date Aug 2, 2018
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joel BEATTY

Person

Patents Grantslast 30 patents

Inhibitors of ARG1 and/or ARG2

Azolopyrimidine for the treatment of cancer-related disorders

Compounds as inhibitors of AXL

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Inhibitors of HIF-2α and methods of use thereof

CD73 inhibitors

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

Azolopyrimidine for the treatment of cancer-related disorders

Azolopyrimidine for the treatment of cancer-related disorders

Patents Applicationslast 30 patents

COMPOUNDS AS INHIBITORS OF AXL

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

COMPOUNDS AS INHIBITORS OF AXL

INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF

2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS

INHIBITORS OF HIF-2ALPHA

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS

INHIBITORS OF ARG1 AND/OR ARG2

CD73 INHIBITORS

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS